Ian Winters
Ian Winters
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
SH Chiou, IP Winters, J Wang, S Naranjo, C Dudgeon, FB Tamburini, ...
Genes & development 29 (14), 1576-1585, 2015
1782015
Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice
ZN Rogers, CD McFarland, IP Winters, JA Seoane, JJ Brady, S Yoon, ...
Nature genetics 50 (4), 483-486, 2018
632018
A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo
ZN Rogers, CD McFarland, IP Winters, S Naranjo, CH Chuang, D Petrov, ...
Nature methods 14 (7), 737-742, 2017
602017
RNA interference in marine and freshwater sponges: actin knockdown in Tethya wilhelma and Ephydatia muelleri by ingested dsRNA expressing bacteria
AS Rivera, JU Hammel, KM Haen, ES Danka, B Cieniewicz, IP Winters, ...
BMC biotechnology 11 (1), 1-15, 2011
502011
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
IP Winters, SH Chiou, NK Paulk, CD McFarland, PV Lalgudi, RK Ma, ...
Nature communications 8 (1), 1-16, 2017
462017
The evolution and function of the Pax/S ix regulatory network in sponges
A Rivera, I Winters, A Rued, S Ding, D Posfai, B Cieniewicz, K Cameron, ...
Evolution & Development 15 (3), 186-196, 2013
412013
Towards quantitative and multiplexed in vivo functional cancer genomics
IP Winters, CW Murray, MM Winslow
Nature Reviews Genetics 19 (12), 741-755, 2018
322018
An LKB1–SIK axis suppresses lung tumor growth and controls differentiation
CW Murray, JJ Brady, MK Tsai, C Li, IP Winters, R Tang, L Andrejka, ...
Cancer discovery 9 (11), 1590-1605, 2019
292019
Tumor suppressor activity of Selenbp1, a direct Nkx2-1 target, in lung adenocarcinoma
DR Caswell, CH Chuang, RK Ma, IP Winters, EL Snyder, MM Winslow
Molecular Cancer Research 16 (11), 1737-1749, 2018
182018
Zmat3 is a key splicing regulator in the p53 tumor suppression program
KT Bieging-Rolett, AM Kaiser, DW Morgens, AM Boutelle, JA Seoane, ...
Molecular Cell 80 (3), 452-469. e9, 2020
62020
Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma
C Li, WY Lin, H Rizvi, H Cai, CD McFarland, ZN Rogers, M Yousefi, ...
Cancer Research 81 (17), 4570-4580, 2021
32021
Compositions and methods for multiplexed quantitative analysis of cell lineages
MM Winslow, D Petrov, IP Winters, C McFarland, ZN Rogers
US Patent App. 17/017,290, 2021
2021
Compositions and methods for multiplexed quantitative analysis of cell lineages
MM Winslow, D Petrov, IP Winters, C McFarland, ZN Rogers
US Patent App. 16/909,806, 2021
2021
Compositions and methods for multiplexed quantitative analysis of cell lineages
MM Winslow, D Petrov, IP Winters, C McFarland, ZN Rogers
US Patent 10,801,021, 2020
2020
Compositions and methods for multiplexed quantitative analysis of cell lineages
MM Winslow, D Petrov, IP Winters, C McFarland, ZN Rogers
US Patent 10,738,300, 2020
2020
Multiplexed functional cancer genomics.
H Cai, C Li, SK Chew, M Yousefi, G Foggetti, WY Lin, ZN Rogers, ...
CANCER RESEARCH 80 (11), 23-23, 2020
2020
Abstract IA26: Multiplexed functional cancer genomics
H Cai, C Li, SK Chew, M Yousefi, G Foggetti, WY Lin, ZN Rogers, ...
Cancer Research 80 (11 Supplement), IA26-IA26, 2020
2020
Abstract IA03: Functional lung cancer genomics through in vivo genome editing
IP Winters, ZN Rogers, CD McFarland, PV Lalgudi, SH Chiou, MA Kay, ...
Clinical Cancer Research 24 (17 Supplement), IA03-IA03, 2018
2018
21 CRISPR/Cas9-based In Vivo Models of Cancer
PV Lalgudi, MM Winslow, IP Winters
Genome Editing and Engineering: From TALENs, ZFNs and CRISPRs to Molecular …, 2018
2018
Quantitative and multiplex analysis of the genomic determinants of tumorigenesis.
I Winters, Z Rogers, C McFarland, D Petrov, MM Winslow
CANCER RESEARCH 78 (10), 15-16, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20